Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
X-ray absorption via iodine content refers to the pronounced attenuation (absorption) of X-rays when they encounter iodine atoms, especially near the iodine K-edge at 33.2 keV[5][3][7]. This physical property results from iodine’s high atomic number (Z=53), which makes it particularly effective at blocking or absorbing X-rays relative to elements present in soft tissue. In medicine, iodine’s X-ray absorption properties are utilized by incorporating iodine into contrast agents for imaging (commonly as non-ionic iodinated compounds)[3][7]. These agents are administered to patients to enhance the visibility of blood vessels, tissues, or organs during radiographic procedures. Iodine’s high X-ray absorption is based on physical—not biological—principles and is not a receptor or molecular target. It does not act via a pathway or mechanism typical of enzyme, receptor, or transporter targets[5][3][7]. Additional context: Contrast agents: While many drugs (contrast media) contain iodine and exploit its X-ray absorption, they are not 'interacting' with iodine as a molecular target; rather, they physically contain iodine to confer X-ray opacity[3][7]. Mechanism of action for contrast agents: Contrast agents act by physical attenuation of X-rays, not by engaging a molecular or cellular biological target—unlike drugs that target receptors, enzymes, or transporters[3][5][7]. Safety concerns: Allergic reactions, thyroid dysfunction, and nephrotoxicity (contrast-induced nephropathy) are known concerns with iodinated contrast agents, but these pertain to the compounds, not to "X-ray absorption via iodine content" as a target. Summary for mapping: This phrase does not describe a canonical target, receptor, or molecular entity suitable for that type of structured annotation. It is a physical property of the element iodine and best classified under "Other" for molecular classification and excluded from target-based drug or biomarker databases[3][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on X-ray absorption by iodine.